Cullinan Therapeutics (CGEM) Total Liabilities: 2020-2023
Historic Total Liabilities for Cullinan Therapeutics (CGEM) over the last 3 years, with Sep 2023 value amounting to $25.9 million.
- Cullinan Therapeutics' Total Liabilities fell 16.78% to $25.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $25.9 million, marking a year-over-year decrease of 16.78%. This contributed to the annual value of $26.1 million for FY2022, which is 120.88% up from last year.
- According to the latest figures from Q3 2023, Cullinan Therapeutics' Total Liabilities is $25.9 million, which was up 15.53% from $22.4 million recorded in Q2 2023.
- Over the past 5 years, Cullinan Therapeutics' Total Liabilities peaked at $62.6 million during Q2 2022, and registered a low of $5.8 million during Q2 2021.
- Over the past 3 years, Cullinan Therapeutics' median Total Liabilities value was $22.4 million (recorded in 2023), while the average stood at $22.8 million.
- Per our database at Business Quant, Cullinan Therapeutics' Total Liabilities soared by 977.43% in 2022 and then plummeted by 64.22% in 2023.
- Over the past 4 years, Cullinan Therapeutics' Total Liabilities (Quarterly) stood at $14.4 million in 2020, then decreased by 17.94% to $11.8 million in 2021, then surged by 120.88% to $26.1 million in 2022, then dropped by 16.78% to $25.9 million in 2023.
- Its Total Liabilities stands at $25.9 million for Q3 2023, versus $22.4 million for Q2 2023 and $29.3 million for Q1 2023.